Published January 1992 | Version v1
Journal article

Technetium-99m hexamethyl propylene amine oxine leucocytes in the assessment of disease activity in inflammatory bowel diseases

  • 1. Paeijaet-Haeme Central Hospital, Lahti (Finland). Dept. of Radiology
  • 2. Paeijaet-Haeme Central Hospital, Lahti (Finland). Dept. of Pathology
  • 3. Paeijaet-Haeme Central Hospital, Lahti (Finland). Dept. of Internal Medicine
  • 4. Paeijaet-Haeme Central Hospital, Lahti (Finland). Dept. of Nuclear Medicine
  • 5. Helsinki Univ. Central Hospital (Finland). Dept. of Radiodiagnostic

Description

The inflammatory activity in 108 bowel segments of 40 patients with suspected or known inflammatory bowel disease was assessed macroscopically by endoscopy, histology and technetium-99m hexamehtyl propylene amine oxine (99mTc-HMPAO) leucocytes using a numerical grading system (scores 0-3). A 4-h series of scintigrams showed a significant correlation with both histological and macroscopical assessment of disease activity (rho=0.850, P<0.001 and rho=0.773, P<0.001, respectively). Sensitivity, specificity and accuracy of scintigraphy in detecting active inflammatory segments were 85%, 92% and 89%, respectively. A normal scintigram did not completely exclude mild inflammatory activity, especially in the rectosigmoid area. 99mTc-HMPAO leucocytes offer an accurate and non-invasive alternative for the assessment of disease activity in ulcerative colitis and Crohn's disease. (orig.)

Additional details

Publishing Information

Journal Title
European Journal of Nuclear Medicine
Journal Volume
19
Journal Issue
1
Series
Eur. J. Nucl. Med.
Journal Page Range
14-18
ISSN
0340-6997
CODEN
EJNMD